These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 3149416

  • 1. Hypoprothrombinemia in the compensated form of hepatosplenic schistosomiasis: further studies.
    Manoukian N, Borges DR.
    Rev Inst Med Trop Sao Paulo; 1988; 30(4):274-80. PubMed ID: 3149416
    [No Abstract] [Full Text] [Related]

  • 2. [Prothrombin and prokallikrein in a patient with hepatosplenic schistosomiasis: effects of heparinization and splenectomy].
    Borges DR, Pardini DP, Chehter L.
    AMB Rev Assoc Med Bras; 1989; 35(1):39-40. PubMed ID: 2513623
    [No Abstract] [Full Text] [Related]

  • 3. Evaluation of the cytokines IL-10 and IL-13 as mediators in the progression of Symmers fibrosis in patients with hepatosplenic schistosomiasis mansoni.
    Brandt CT, Rino M, Pitta MG, Muniz JS, Silveira Dde O, Castro CM.
    Rev Col Bras Cir; 2010 Oct; 37(5):333-7. PubMed ID: 21180998
    [Abstract] [Full Text] [Related]

  • 4. [Hepatosplenic schistosomiasis mansoni: a tragic disease].
    de Oliveira-e-Silva A, D'Albuquerque LA.
    Arq Gastroenterol; 2003 Oct; 40(4):201-2. PubMed ID: 15264039
    [No Abstract] [Full Text] [Related]

  • 5. Enzyme activities and protein concentrations in serum of patients with hepatosplenic schistosomiasis.
    Abdel-Rahim IM, Kaiser C, Homeida M, Elsheikh M, Schmidt E, Ehrich JH, Doehring-Schwerdfeger E.
    Trop Med Parasitol; 1990 Sep; 41(3):262-4. PubMed ID: 1701559
    [Abstract] [Full Text] [Related]

  • 6. [Functional and immunologic evaluation of prothrombin in the hepatosplenic form of schistosomiasis and hepatic cirrhosis].
    Manoukian N, Borges DR.
    Rev Paul Med; 1983 Sep; 101(5):182-5. PubMed ID: 6672979
    [No Abstract] [Full Text] [Related]

  • 7. Prealbumin, prekallikrein and prothrombin in hepatosplenic schistosomiasis: increased turnover of the clotting proteins?
    Manoukian N, Borges DR.
    Rev Inst Med Trop Sao Paulo; 1984 Sep; 26(5):237-40. PubMed ID: 6570691
    [No Abstract] [Full Text] [Related]

  • 8. Serum beta-2-microglobulin in intestinal and hepatosplenic bilharziasis.
    Nasser HE, Amer MS, Taha MA, Shawkat A, Abo-Elmaged L, El Missiry AG, Khalil I, Schoukry NA, Abdel Mohsen A, Soliman H.
    J Egypt Soc Parasitol; 1983 Dec; 13(2):423-7. PubMed ID: 6363570
    [No Abstract] [Full Text] [Related]

  • 9. Serum transferrin, albumin and IgG levels in hepatosplenic bilharziasis in Egypt.
    Saif M, Tawfik J, Ali MA, El-Mahrouky SF, Galil N, Galal MN.
    J Egypt Med Assoc; 1977 Dec; 60(9-12):731-43. PubMed ID: 753855
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Blood gastrin in the hepatosplenic form of schistosomiasis mansoni].
    Borges DR, Neves MM, Vilela MP.
    AMB Rev Assoc Med Bras; 1978 Oct; 24(10):336. PubMed ID: 311048
    [No Abstract] [Full Text] [Related]

  • 13. Alterations in the fatty acyl composition of plasma cholesteryl esters in Brazilian patients with hepatosplenic schistosomiasis mansoni.
    Gillett MP, Sibrian AM, Dimenstein R, Carvalho VC, Gonçalves MM, Chaves-Filho M.
    Braz J Med Biol Res; 1989 Oct; 22(8):949-57. PubMed ID: 2517406
    [Abstract] [Full Text] [Related]

  • 14. A, B, O blood groups and hepatosplenic form of schistosomiasis mansoni (Symmer's fibrosis).
    Pereira FE, Bortolini ER, Carneiro JL, da Silva CR, Neves RC.
    Trans R Soc Trop Med Hyg; 1979 Oct; 73(2):238. PubMed ID: 473313
    [No Abstract] [Full Text] [Related]

  • 15. Praziquantel in the treatment of hepatosplenic schistosomiasis: biochemical disease markers indicate deceleration of fibrogenesis and diminution of portal flow obstruction.
    Zwingenberger K, Richter J, Vergetti JG, Feldmeier H.
    Trans R Soc Trop Med Hyg; 1990 Oct; 84(2):252-6. PubMed ID: 2117787
    [Abstract] [Full Text] [Related]

  • 16. [Characteristics of the inflammatory reaction in patients with hepatosplenic forms of schistosomiasis mansoni and kala-azar].
    Fernandes DJ, Rocha H.
    Rev Inst Med Trop Sao Paulo; 1967 Oct; 9(3):129-34. PubMed ID: 5604164
    [No Abstract] [Full Text] [Related]

  • 17. [Hypocoagulability: a new indication for splenectomy in hepatosplenic mansonic schistosomiasis].
    Barone B, de Guerra CC, Borges DR, de Oliveira E, de Silva MP, Vilela MP, Goldenberg S.
    AMB Rev Assoc Med Bras; 1973 Oct; 19(10):393-6. PubMed ID: 4544593
    [No Abstract] [Full Text] [Related]

  • 18. Tumour necrosis factor in hepatosplenic schistosomiasis.
    Zwingenberger K, Irschick E, Vergetti Siqueira JG, Correia Dacal AR, Feldmeier H.
    Scand J Immunol; 1990 Feb; 31(2):205-11. PubMed ID: 2106723
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The coagulation profile in hepatosplenic schistosomiasis.
    El-Bassiouni NE, El Bassiouny AE, Hussein NA, El-Sayed HH, Ibrahim IM, Lotfy MG, Omran SA.
    Blood Coagul Fibrinolysis; 1998 Mar; 9(2):189-94. PubMed ID: 9622218
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.